Juan-Ramón Larrubia

8PUBLICATIONS
15CO-AUTHORS
Predictive and prognostic markersSite-based writingHaematologyHaematological tumoursRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 25, 2026
Cumulative Metformin Use and Hepatocellular Carcinoma Risk After HCV SVR: A Multicentre Cohort Study.

|Dec 01, 2022
A new year and a new roadmap for the journal in challenging times.

Conrado M Fernandez Rodriguez, Juan Ramón Larrubia Marfil

|Sep 28, 2022
Letter: the probability to predict HBV-specific CD8+ cell response derived from HLA-A2+ may not foresee the functional cure well in Asian off-therapy cohort-authors' reply.

Julia Peña-Asensio, Henar Calvo, Joaquín Miquel

|Jul 22, 2022
Current challenges in the functional cure of HBe-Antigen-negative chronic hepatitis B.

Henar Calvo Sánchez, Julia Peña-Asensio, Juan Ramón Larrubia Marfil

|Feb 28, 2022
Model to predict on-treatment restoration of functional HBV-specific CD8+ cell response foresees off-treatment HBV control in eAg-negative chronic hepatitis B.

Julia Peña-Asensio, Henar Calvo, Joaquín Miquel

|Apr 30, 2021
Anti-PD-1/PD-L1 Based Combination Immunotherapy to Boost Antigen-Specific CD8+ T Cell Response in Hepatocellular Carcinoma.

Julia Peña-Asensio, Henar Calvo, Miguel Torralba

Pageof 2

Frequent Collaborators

3 joint publications

Julia Peña-Asensio

2 joint publications

Henar Calvo-Sánchez

2 joint publications

Conrado M Fernandez Rodriguez

1 joint publications

Lorena Jara-Fernández